Month: March 2022

PRINCETON, N.J., March 11, 2022 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that Chairman and Chief Executive Officer Al Altomari will participate in two upcoming investor conferences, including a live panel discussion on drug development in Women’s Health.Oppenheimer’s 32nd Annual Virtual Healthcare ConferenceFireside ChatThursday, March 17, 2022 at 2:00 p.m. ETMaxim Group and M-Vest 2022 Virtual Growth ConferenceAdvances in Women’s Health, from Clinical to Commercial Live Panel DiscussionMonday, March 28, 2022 at 3:00 p.m. ETLinks and webcast information for each conference can be found on the Investors section of the Agile Therapeutics website at https://ir.agiletherapeutics.com/events-and-presentations. Each archived webcast will be available...

WORCESTER, Mass., March 11, 2022 (GLOBE NEWSWIRE) — Mass Megawatts Wind Power, Inc. (OTC Pink: MMMW) reports a very good cash position allowing the opportunity for achieving its goals of producing sales toward the path of profitability. The Company can move forward with new product manufacturing and a few small commercial sales of the new patent pending solar tracker. The use of solar trackers is known to reduce the cost of solar powered electricity. Although Mass Megawatts is aiming to achieving a very small fraction of global demand, the solar tracker market is anticipated to be worth more than $3 billion by 2025 expanding from the current market size of about $2 billion. Mass Megawatts sees an opportunity to be part of the growing solar tracker market with a lower cost product than the trackers marketed by other solar tracker...

SANTA CLARA, Calif., March 11, 2022 (GLOBE NEWSWIRE) — Applied Materials, Inc. today announced that its Board of Directors has approved a new $6 billion share repurchase authorization, supplementing the previous authorization which had $3.2 billion remaining at the end of the first quarter of fiscal 2022. In addition, the Board approved an 8.3-percent increase in the quarterly cash dividend from $0.24 to $0.26 per share, marking the fifth consecutive annual dividend increase. The dividend is payable on June 16, 2022 to shareholders of record as of May 26, 2022. “The new share repurchase authorization and dividend increase demonstrate Applied Materials’ confidence in the long-term growth of our markets, the strength of our technology, and our ability to generate strong cash flow and attractive shareholder returns,” said Gary Dickerson,...

PALO ALTO, Calif., March 11, 2022 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that it will host an investor call on March 14, 2022, at 8:00 AM ET to discuss data from its Phase 2 study of BBP-418 in patients with limb-girdle muscular dystrophy type 2i (LGMD2i). The results will be featured at the Muscular Dystrophy Association (MDA) 2022 Annual Meeting, taking place in Nashville, Tennessee on March 13 – 16, 2022. With approximately 7,000 patients in the U.S. and European Union with potentially treatable mutations, LGMD2i is an inherited autosomal recessive muscular dystrophy caused by partial loss of function mutations in fukutin-related protein (FKRP) which results in hypoglycosylation...

LOS ANGELES, March 11, 2022 (GLOBE NEWSWIRE) — FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT), a leading global franchising company and parent company of iconic brands including Round Table Pizza, Fatburger, Marble Slab Creamery, Johnny Rockets, Twin Peaks, Fazoli’s and 11 other restaurant concepts, today announced that the Company will host a conference call to review its fourth quarter and full year 2021 financial results on Monday, March 21, 2022 at 5:00 PM ET. A press release with fourth quarter and full year 2021 financial results will be issued prior to the conference call that day. The conference call can be accessed live over the phone by dialing 1-877-705-6003 from the U.S. or 1-201-493-6725 internationally. A replay will be available after the call until Monday, March 28, and can be accessed by dialing 1-844-512-2921...

Monday, March 14th @ 11 am ET, registration details below NEW YORK, March 11, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, announced today that it will host a virtual Key Opinion Leader (KOL) webinar event, “Foralumab Clinical Update in Multiple Sclerosis: A Landmark Study with Intranasal Immunotherapy” on Monday, March 14, 2022 at 11:00 am Eastern Time. This webinar will feature presentations to discuss clinical data and importance of intranasal immunotherapy with foralumab in neurodegenerative diseases. Prof. Howard Weiner, MD, from Harvard Medical School, Prof. Tanuja Chitnis, MD, from Massachusetts General Hospital, Prof. Tarun Singhal, MD, from Brigham and Women’s Hospital and Prof....